Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Assessment of Anxiety in Clinical Trials with Depressed Patients
1
x
$
30.00
View Cart
Checkout
Home
Thomas L. Schwartz, MD: The Use of Tiagabine Augmentation for Treatment-Resistant Anxiety Disorders: A Case Series
“Assessment of Anxiety in Clinical Trials with Depressed Patients” has been added to your cart.
View cart
Thomas L. Schwartz, MD: The Use of Tiagabine Augmentation for Treatment-Resistant Anxiety Disorders: A Case Series
$
30.00
Thomas L. Schwartz, MD: The Use of Tiagabine Augmentation for Treatment-Resistant Anxiety Disorders: A Case Series quantity
Add to cart
Want a discount? Become a member by purchasing
Psychopharmacology Bulletin Subscription - Individual
!
Categories:
Psychopharmacology Bulletin
,
VOL 36 No. 2 Articles
Tags:
anxiety-disorder
,
anxiolytic
,
medworks-media
,
pharmacotherapy
,
psychopharmacology-bulletin
,
thomas-l-schwartz
,
tiagabine
,
treatment-resistance
Description
Description
Thomas L. Schwartz, MD
COMPLICATED CASE HISTORIES
The Use of Tiagabine Augmentation for Treatment-Resistant
Anxiety Disorder
s: A Case Series
Thomas L. Schwartz, MD
Related products
Quetiapine XR Negative Clinical Trials Report by Gang Wang
$
30.00
Add to cart
Details
Long Acting Risperidone in an Adolescent – Mustafa Deniz Tutkunkardas
$
30.00
Add to cart
Details
Quetiapine XR Randomized, Double-Blind Study by Arifulla Khan
$
30.00
Add to cart
Details
Antipsychotics Case Study by Yuan-Hwa Chou
$
30.00
Add to cart
Details
Page load link
Go to Top
